﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>HPB Surgery</title><link>http://www.hindawi.com</link><description>The latest articles from Hindawi Publishing Corporation</description><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright><item><title>Lessons from Laparoscopic Liver Surgery: A Nine-Year Case Series</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/458137</link><description>Objective. This series describes a developing experience in laparoscopic liver surgery presenting results from 40 procedures including right hemihepatectomy, left lateral lobectomy, and microwave ablation therapy. Methods. Forty patients undergoing laparoscopic liver surgery between September 1997 and November 2006 were included. The data set includes: operative procedure and duration, intraoperative blood loss, conversion to open operation rates, length of hospital stay, complications, mortality, histology of lesions/resection margins, and disease recurrence. Results. Mean age of patient: 59 years, 17/40 male, 23/40 female, 23/40 of lesions were benign, and 17/40 malignant. Operations included: laparoscopic anatomical resections n=15, nonanatomical resections n=11, microwave ablations n=8 and deroofing of cysts n=7.  Median anaesthetic time: 120 minutes (range 40&amp;#8211;240), mean blood loss 78&amp;#x2009;mL and 1/40  conversions to open. Median resection margins were 10&amp;#x2009;mm (range 1&amp;#8211;14) and median length of stay 3 days (range 1&amp;#8211;10). Operative and 30-day mortality were zero with no local disease recurrence. Conclusion. Laparoscopic liver surgery appears safe and effective and is associated with reduced hospital stay. Larger studies are required to confirm it is oncologically sound.</description><Author>Laura Spencer, Matthew S. Metcalfe, Andrew D. Strickland, Elisabeth J. Elsey, Gavin S. Robertson, and David M. Lloyd</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Gallstone-Induced Perforation of the Common Bile Duct in Pregnancy</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/174202</link><description>Spontaneous perforation of the extrahepatic biliary system is a rare presentation of ductal stones. We report the case of a twenty-year-old woman presenting at term with biliary peritonitis caused by common bile duct (CBD) perforation due to an impacted stone in the distal common bile duct. The patient had suffered a single herald episode of acute gallstone pancreatitis during the third trimester. The patient underwent an emergency laparotomy, bile duct exploration, and removal of the ductal stone. The postoperative course was uneventful.</description><Author>N. Dabbas, M. Abdelaziz, K. Hamdan, B. Stedman, and M. Abu Hilal</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Pancreatic Mass with an Unusual Pathology: A Case Report</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/374602</link><description>Intra-abdominal abscesses formation in patients with no preceding symptoms is rare. Infection of the pancreas occurs in 5&amp;#x2013;9&amp;#x0025; of patients with acute pancreatitis, more commonly as a complication of necrotising or severe pancreatitis. We have reported a case of a 64-year-old almost entirely asymptomatic man who underwent a Whipple's procedure following extensive investigation of a pancreatic mass. The pathology and histology showed no evidence of malignancy, and instead a true pancreatic abscess, centred around an impacted cholesterol calculus in the distal CBD. Of suspicious pancreatic masses that are resected, chronic choledocholithiasis is the aetiology in less than 5&amp;#x0025; of nonmalignant or &amp;#x0093;false positives.&amp;#x0094; This report describes such a case.</description><Author>Andrew J. Healey, Anna Reed, and Long R. Jiao</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Lymphoplasmacytic Sclerosing Pancreatitis and Retroperitoneal Fibrosis</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/719513</link><description>Although cases of lymphoplasmacytic sclerosing pancreatitis (LSP) associated with idiopathic retroperitoneal fibrosis have been reported, the association is rare. We describe a 74-year-old man who presented with obstructive jaundice and weight loss. Nineteen months earlier, he had been diagnosed with idiopathic retroperitoneal fibrosis and treated with bilateral ureteric stents.  Initial investigations were suggestive of a diagnosis of LSP, however, a malignant cause could not be ruled out. He underwent an exploratory laparotomy and frozen sections confirmed the diagnosis of LSP. An internal biliary bypass was performed using a Roux loop of jejunum, and the patient made an uneventful recovery. This case illustrates the difficulty in distinguishing LSP from pancreatic carcinoma preoperatively.</description><Author>Nigel K. F. Koo Ng, Jin J. Bong, and Robin C. Williamson</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Pancreaticoduodenectomy: Volume is not Associated with Outcome within an Academic Health Care System</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/825940</link><description>Hypothesis. Smaller and lower-volume hospitals can attain surgical outcomes similar to high-volume centers if they incorporate the expertise and health care pathways of high-volume centers. Setting. The academic tertiary care center, Moffit-Long Hospital (ML); the community-based Mount Zion Hospital (ZION); the San Francisco County General Hospital (SFGH); and the Veterans Affairs Medical Center of San Francisco (VAMC). Patients. 369 patients who underwent pancreaticoduodenectomy between October 1989 and June 2003 at the University of California, San Francisco (UCSF) affiliated hospitals. Interventions. Pancreaticoduodenectomy. Design. Retrospective chart review. To correct for the potentially confounding effect of small case volumes and event rates, data for SFGH, VAMC, and ZION was combined (Small Volume Hospital Group; SVHG) and compared against data for ML.
Main Outcome Measures. Complication rates; three-year and five-year survival rates. Results. The average patient age and health, as determined by ASA score, were similar between ML and the SVHG. The postoperative complication rate did not differ significantly between ML and the SVGH (58.8&amp;#x0025; versus 63.1&amp;#x0025;). Patients that experienced a complication averaged 2.5 complications in both groups. The perioperative mortality rate was 4&amp;#x0025; for patients undergoing pancreaticoduodenectomy at either ML or the SVGH. Although the 3-year survival rate for patients with adenocarcinoma of the pancreas was nearly twice as high at ML (31.2&amp;#x0025; versus 18.3&amp;#x0025; at SVHG), there was no significant difference in the 5-year survival rates (19&amp;#x0025; at ML versus 18.3&amp;#x0025; at SVHG). Conclusions. Low-volume hospitals can achieve similar outcomes to high-volume tertiary care centers provided they import the expertise and care pathways necessary for improved results.</description><Author>Micheal T. Schell, Anthony Barcia, Austin L. Spitzer, and Hobart W. Harris</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Evolving Role of Endoscopic Retrograde Cholangiopancreatography in Management of Extrahepatic Hepatic Ductal Injuries due to Blunt Trauma: Diagnostic and Treatment Algorithms</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/259141</link><description>Extrahepatic hepatic ductal injuries (EHDIs) due to blunt abdominal trauma are rare. Given the rarity of these injuries and the insidious onset of symptoms, EHDI are commonly missed during the initial trauma evaluation, making their diagnosis difficult and frequently delayed. Diagnostic modalities useful in the setting of EHDI include computed tomography (CT), abdominal ultrasonography (AUS), nuclear imaging (HIDA scan), and cholangiography. Traditional options in management of EHDI include primary ductal repair with or without a T-tube, biliary-enteric anastomosis, ductal ligation, stenting, and drainage. Simple drainage and biliary decompression is often the most appropriate treatment in unstable patients. More recently, endoscopic retrograde cholangiopancreatography (ERCP) allowed for diagnosis and potential treatment of these injuries via stenting and/or papillotomy. Our review of 53 cases of EHDI reported in the English-language literature has focused on the evolving role of ERCP in diagnosis and treatment of these injuries. Diagnostic and treatment algorithms incorporating ERCP have been designed to help systematize and simplify the management of EHDI. An illustrative case is reported of blunt traumatic injury involving both the extrahepatic portion of the left hepatic duct and its confluence with the right hepatic duct. This injury was successfully diagnosed and treated using ERCP.</description><Author>Nikhil P. Jaik, Brian A. Hoey, and S. Peter Stawicki</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Management of the Hepatic Lymph Nodes during Resection of Liver Metastases from Colorectal Cancer: A Systematic Review</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2008/684150</link><description>Background. Hepatic lymph node involvement is generally considered a contraindication for liver resection performed for colorectal liver metastases. However, some advocate hepatic lymphadenectomy in the presence of macroscopic involvement and others routine lymphadenectomy. The aim of this review is to assess the role of lymphadenectomy in resection of liver metastases from colorectal cancer. Methods. Medline, Embase and Central databases were searched using a formal search strategy. Trials with survival data with a minimum follow-up of 1 year were considered for inclusion. Meta-analysis was performed using Revman. Results. A total of 4230 references were identified. Ten reports of nine studies including 926 patients qualified for the review. The prevalence of nodal metastases after routine lymphadenectomy was 16.3&amp;#37;. The overall 3-year and 5-year survival rates in node-positive patients were 9/151 (11.3&amp;#37;) and 2/137 (1.5&amp;#37;), respectively, compared to 3-year and 5-year survival rates of 424/787 (53.9&amp;#37;) and 246/767 (32.1&amp;#37;) in node-negative patients. The odds ratios for 3-year and 5-year survivals in node positive disease compared to node-negative disease were 0.12 (95&amp;#37; CI 0.06 to 0.24) and 0.08 (95&amp;#37; CI 0.03 to 0.22). There was no randomized controlled trial which assessed the survival benefit of routine or &amp;#x0201C;selective&amp;#x0201D; lymphadenectomy. Conclusion. Currently, there is no evidence of survival benefit for routine or selective lymphadenectomy. Survival rates are low in patients with positive lymph nodes draining the liver irrespective of whether they are detected by routine lymphadenectomy or by macroscopic involvement. Further trials in this patient group are required.</description><Author>Kurinchi S. Gurusamy, Charles Imber, and Brian R. Davidson</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Hepatic Metastases of Granulosa Cell Tumour of the Ovary</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/13452</link><description>A case of metastatic granulosa cell tumour of the ovary is reported. Investigations revealed a secondary tumour in segment VI and VII of the liver. Right hepatic resection was performed. Microscopic findings revealed a tumour with histological features identical to that removed eleven years before.</description><Author>Jos&amp;#233; I. Rodr&amp;#237;guez Garc&amp;#237;a, Juan. J. Gonz&amp;#225;lez Gonz&amp;#225;lez, Luis J. Garc&amp;#237;a Fl&amp;#243;rez, Paloma Floriano Rodr&amp;#237;guez, and Enrique Mart&amp;#237;nez Rodr&amp;#237;guez</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Type IVA Choledochal Cyst: Is Hepatic Resection Necessary&amp;#63;</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/17026</link><description>Background: This study concerns patients who have choledochal cyst with intrahepatic and extrahepatic involvement (type IVA cyst). The extent of excision and the necessity of hepatectomy, including the intrahepatic cyst in these patients have not been clarified.</description><Author>Russell Strong</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>The Ability of Bile to Scavenge Superoxide Radicals and Pigment Gallstone Formation in Guinea Pigs</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/20687</link><description>After partial ligation of the common bile duct (CBD) of guinea pigs, 14 of 16 animals developed pigment gallstones within one week (S group). Intraperitoneal injection of Vit. E and C, each 10 mg/kg daily from 3 days before CBD ligation to one week after the operation (S&amp;#43;V group), decreased the gallstone incidence to 5/14 (exact probability&amp;#60;0.01). The gallstone incidence in the control group, that only received laparotomy without ligation of the CBD, was 0/15. Biochemical analysis of the gallbladder bile showed that stricture of the CBD was associated with a significant increase in levels of unconjugated bilirubin (UCB) and Ca2&amp;#43; (p&amp;#60;0.05 and &amp;#60;0.01). Simultaneously the scavenging rate (SR) of superoxide radical in bile significantly decreased (p&amp;#60;0.05). Comparing S&amp;#43;V group with S group, the effect of Vit. E and C on the concentrations of UCB and Ca2&amp;#43; in bile was not significant (both p&amp;#62;0.05), but Vit. E and C normalized the SR, and the difference between S group and S&amp;#43;V group was significant (p&amp;#60;0.05). These results suggested that Vit. E and C, known as antioxidants, enhanced the ability to scavenge oxygen radical in S&amp;#43;V group; and that in addition to the increases of UCB and Ca2&amp;#43; concentrations, the participation of oxygen radicals might be of importance for pigment gallstone formation induced by bile duct obstruction.</description><Author>Cong Lin, Tao Shen, Xianbo Fu, and Xiaosi Zhou</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Cystic Dilatations of the Common Bile Duct in Adults</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/28924</link><description>Cystic dilatations of the common bile duct are believed to be of congenital etiology with most cases presenting in childhood. During the last 20 years, 10 patients with cystic dilatations of the bile duct were treated in our Department. There were 5 men and 5 women with an age range of 35&amp;#8211;81 years. Clinical presentation consisted of right hypohondrial pain, nausea, vomiting and a history of obstructive jaundice. Diagnosis was established by ultrasound, cholangiography and ERCP in most cases. According to the Todani classification system, 5 patients had type I cysts, 4 had type II and one had type III. At the time of surgery, main associated diseases were choledocholithiasis in 3 cases and cholangitis in 2 cases. One patient (type III) underwent endoscopic sphincterotomy; 4 patients underwent internal drainage and 2 of them developed mild cholangitis postoperatively; 5 patients underwent excision of the cyst and a biliary-enteric bypass and developed no main complications. Patients remained in good health during long-term follow-up. We conclude that cyst excision is the treatment ofchoice for adults in order to reduce postoperative morbidity and the potential risk of malignancy.</description><Author>Gr. Kouraklis, E. Misiakos, A. Glinavou, G. Karatzas, J. Gogas, and G. Skalkeas</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Villous Adenocarcinoma of the Duodenum Invading the Ampulla of Vater: Case Report and Review of Literature</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/32596</link><description>We report a case of villous adenocarcinoma of duodenum arising from the ampulla of Vater with a review of the literature. Although preoperative endoscopic biopsies were performed, no malignancy was identified. Because of the pathological uncertainty we decided to perform a pylorus-preserving pancreatoduodenectomy. Microscopic examination demonstrated glandular dysplasia with aspects of villous adenoma and well differentiated adenocarcinoma. We conclude that both in malignant cases and in cases with uncertain diagnosis a pylorus-preserving pancreatoduodenectomy is the best surgical treatment because it results in better 5 year survival.</description><Author>Gaetano Catania, Francesco Cardi, Marcello Migliore, and Gaetano Romeo</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>The Management of Extrahepatic Portal Vein Aneurysms: Observe or Treat&amp;#63;</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/37169</link><description>A case of a 70 year old man who was found to have an extrahepatic portal vein aneurysm during an evaluation for hematuria is reported. Extrahepatic portal vein aneurysms are rare with only twenty cases reported in the literature. Typically, patients present with hemorrhage requiring surgical exploration or the aneurysm is discovered during evaluation of another abdominal process. Management includes careful follow-up in the asymptomatic patient without underlying liver disease or portal hypertension.</description><Author>Philip D. Feliciano, Joseph J. Cullen, and John D. Corson</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/39486</link><description>Bleeding from oesophageal varices, oesophageal ulcers or oesophagitis is occasionally massive and difficult to control. Octreotide, a synthetic analogue of somatostin lowers portal pressure and collateral blood flow including that through varices, increases lower oesophageal sphincter pressure, and inhibits the gastric secretion of acid as well as pepsin. Our current experience suggests it is effective in controlling acute variceal haemorrhage. Therefore we have examined the efficacy of octreotide in the control of postsclerotherapy bleeding from oesophageal varices, oesophageal ulcers and oesophagitis. During the study period 77 patients experienced a significant gastrointestinal bleed (blood pressure &amp;#60; 100 mm Hg, pulse &amp;#62;100 beats per min or the need to transfuse 2 or more units of blood to restore the haemoglobin level) following injection sclerotherapy of oesophageal varices. The source of bleeding was varices in 42 patients, oesophageal ulcers in 31 and oesophagitis in 4. All patients received a continuous intravenous infusion of octreotide (50 &amp;#956;g/h) for between 40&amp;#8211;140h. If bleeding was not controlled in the first 12h after commencing octreotide hourly bolus doses (50 &amp;#956;g) for 24h were superimposed on the continuous infusion. Haemorrhage was successfully controlled by an infusion of octreotide in 38 of the 42 patients with bleeding from varices, in 30 of 31 patients with oesophageal ulceration, and all patients with oesophagitis. In the 1 patient with persistent bleeding from oesophageal ulceration and in 2 of the 4 with continued haemorrhage from varices, haemostasis was achieved by hourly boluses of 50 &amp;#956;g octreotide for 24h in addition to the continuous infusion. No major complications were associated with octreotide administration. The results of this study clearly indicate that octreotide is a safe and effective treatment for the  control of severe haemorrhage after technically successful injection sclerotherapy.</description><Author>Spencer A. Jenkins, Andrew N. Kingsnorth, Simon Ellenbogen, Graham Copeland, Nicholas Davies, Robert Sutton, and Robert Shields</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Influence of the Gut Microflora and of Biliary Constituents on Morphological Changes in the Small Intestine in Obstructive Jaundice</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/43159</link><description>Increased amounts of intestinal endotoxin are absorbed in obstructive jaundice. The precise mechanism is not known but the increased absorption may arise from alterations in the luminal contents, in the intestinal flora, in the gut wall or in interactions between all three. To examine the effects of the intestinal flora we have compared the morphological changes in the small intestine in obstructive jaundice in germ free and conventional rats while the effects of bile constituents have been examined by addition of bile constituents to the diet of bile duct ligated rats. Changes in the intestine were examined, histologically, by enzyme histochemistry, and by transmission and scanning electron microscopy. The results showed no differences in response between germ free and conventional rats. Feeding of diets containing bile salts exacerbated the lesion. Feeding of diets containing cholesterol, however, reduced the degree of intestinal changes produced by cholestasis and completely antagonised the increase in damage caused by feeding of bile salts.</description><Author>M. Saeed Quraishy, Dawn Chescoe, Jenny Mullervy, Marie Coates, Richard H. Hinton, and Michael E. Bailey</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Liver Resection: Prolonged Inflow Occlusion in Human Cirrhotic Livers</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/45405</link><description>To evaluate the tolerance of the cirrhotic liver to extended warm ischaemia, 47 patients with cirrhosis who underwent liver,resection over a 4-year period were studied retrospectively. Three groups of patients were identified. In group 1 (14 patients) liver resection was performed under conditions of portal triad occlusion ranging from 50 to 75 (mean 57.1) min. Group 2 (12 patients) was treated with portal occlusion for a period ranging from 30 to 42 (mean 33.1) min. Group 3 comprised 21 patients who underwent  hepatectomy using conventional techniques. Mean blood loss was significantly reduced by portal triad occlusion (819 ml in group 1,523 ml in group 2) compared with the conventional techniques (1652 ml in group 3) (P&amp;#60;0.05, group 1 versus group 3; P&amp;#60;0.01, group 2 versus group 3). Hospital death occurred in three of the 21 patients in group 3 but in no patient who underwent portal triad occlusion. The morbidity rate was lower in the two occlusion groups (four of 26 patients) than in group 3 (six of 21). Bilirubin metabolism was substantially better after surgery in the occlusion groups (P&amp;#60;0.05, groups 1 and 2 versus group 3 at day 14). Although the serum levels of transaminases were significantly raised until day 3 in patients undergoing long term occlusion, the cirrhotic liver withstood the ischaemia-reperfusion insult, as assessed by changes in hepatic microcirculation, lipid peroxidation and the morphology of hepatic sinusoids. It is concluded that prolonged ischaemia during liver resection can be sustained in patients with cirrhosis and without high-risk factors.</description><Author>Bengt Jeppsson</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Carcinoid Tumor of the Common Bile Duct</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/51493</link><description>A case of a primary carcinoid tumor of the common bile duct is presented. Diagnostic and therapeutic uncertainties of this extremely rare cause of jaundice are discussed.</description><Author>Doron Kopelman, Moshe Schein, Hedviga Kerner, Hany Bahuss, and Moshe Hashmonai</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Isolated Late Metastasis of a Renal Cell Cancer Treated by Radical Distal Pancreatectomy</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/56065</link><description>A 53&amp;#8211;year-old man underwent right nephrectomy for a locally advanced renal cell carcinoma with concomitant resection of a solitary metastasis in the right lung. Ten years later, he presented with haematochezia caused by a tumour in the tail of pancreas, invading the transverse colon and the greater curvature of the stomach. The tumour was radically resected, and histological examination revealed a solitary metastasis of the previous renal cell carcinoma. This case illustrates a rare indication for pancreatic resection because of pancreatic metastasis.</description><Author>J. P. Barras, H. Baer, A. Stenzl, and A. Czerniak</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Are Hepatic Adenomas Premalignant&amp;#63;</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/59629</link><description>Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas.</description><Author>David M. Nagorney</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Efficacy of Intra-arterial Norcantharidin in Suppressing Tumour 14C-labelled Glucose Oxidative Metabolism in rat Morris Hepatoma</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/63403</link><description>Norcantharidin is the demethylated form of Cantharidin, which is the active ingredient of the blister beetle, Mylabris, a long used Chinese traditional medicine. Though not well publicised outside China, Norcantharidin is known to possess significant anti-hepatoma activity, and is relatively free from side effects. In the present study, glucose oxidation in tumour and liver tissue slices harvested from hepatomabearing animals was quantified by measuring the radioactivity of 14C-labelled CO released from 14C-glucose in oxygen-enriched incubation medium. Results were expressed asa tumour/liver ratio. For comparison, treatments with Norcantharidin, Adriamycin and with hepatic artery ligation were studied. The mean tumour/liver ratio was 4.2&amp;#43;2.2 in untreated controls, but dropped significantly to 2.3&amp;#43;0.5 (p&amp;#60;0.05) with intra-arterial Norcantharidin (0.5 mg/kg) and to 2.3&amp;#43;0.7 (p&amp;#60;0.05) with intra-arterial Adriamycin (2.4 mg/kg), and to 2.2&amp;#43;0.7 (p&amp;#60;0.05) with hepatic artery ligation. However, with intravenous Adriamycin at 2.4 mg/kg, the mean tumour/liver ratio was reduced to only 3.5&amp;#43;2.0 and was not significantly different from untreated controls. It is concluded that intra-arterial Norcantharidin is as effective as intraarterial Adriamycin and hepatic artery ligation in suppressing tumour glucose oxidative metabolism. These results imply that Norcantharidin may have a role to play in the chemotherapy ofprimary livercancer.</description><Author>Peter Mack, Xiao-Fang Ha, and Li-Yao Cheng</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Laparoscopic Cholecystectomy in Cirrhotic Patient</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/67964</link><description>Cholecystectomy is associated with increased risk in patients with liver cirrhosis. Moreover, cirrhosis and portal hypertension have been considered relative or absolute contraindication to laparoscopic cholecystectomy. As experience with laparoscopic cholecystectomy increased, we decided to treat cirrhotic patients via this approach. Between January 1994 and April 1995, nine patients with a Child-Pugh&amp;#39;s stage A cirrhosis underwent elective laparoscopic cholecystectomy with intraoperative cholangiography. There was no significant per- or post-operative bleeding and no blood transfusion was necessary. There was no mortality and very low morbidity. Median hospital stay was 3 days. This series suggests that wellcompensated cirrhosis can not be considered a contraindication to laparoscopic cholecystectomy.</description><Author>Jean Gugenheim, Marco Casaccia Jr., Davide Mazza, James Toouli, Vanna Laura, Pascal Fabiani, and Jean Mouiel</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Laparoscopic vs Open Ultrasound of the Liver:  An in vitro Study</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/71637</link><description>Intra-operative contact ultrasound is a sensitive method of detecting liver tumours. The aim of this study was to compare the sensitivity of open contact ultrasound (OUS) of the liver with laparoscopic contact ultrasound (LUS). Hypoechoic &amp;#8220;lesions&amp;#8221; were created in 5 fresh pig livers by inserting 28 grapes via small incisions in the inferior surface. The size (range 8&amp;#8211;25 mm) and location of each grape was recorded. Scanning was undertaken in random order by two experienced independent observers with no knowledge of the size, number or position of the lesions, using an Aloka 650 series scanner and 7.5 MHz probes. The crude sensitivity with OUS was 96&amp;#37; and 100&amp;#37; respectively for the two observers, and 92&amp;#37; for each with LUS. One grape was interpreted as 2 seperate grapes on LUS by one observer. Absolute sensitivity (grapes identified in the correct location) was 86&amp;#37; and 93&amp;#37; respectively with OUS and 79&amp;#37; for eachobserver with LUS.</description><Author>P. J. Cozzi, J. L. McCall, J. O. Jorgensen, and D. L. Morris</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Pathologic and Radiographic Studies of Intrahepatic Metastasis Hepatocellular Carcinoma; The Role of Efferent Vessels</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/75210</link><description>The efferent vessel of hepatocellular carcinoma (HCC) and the mechanism and pathogenesis of the high frequency of intrahepatic metastasis in HCC has not yet been clarified. Three hundred ninety-three resected specimens of HCC were examined for tumor thrombosis in the portal vein and the hepatic vein: 231 tumors &amp;#8804;5 cm in diameter were examined for the relationship between mode of tumor spread and tumor size. Efferent vessels in HCC were identified by direct injection of radiopaque material into the tumor in 23 resected liver specimens and by percutaneous infusion of radiopaque media into tumor nodules in 8 patients. The mode of tumor spread in HCC progressed from capsular invasion to extracapsular invasion, then to vascular invasion, and finally to intrahepatic metastasis. There was a strong statistical correlation between the presence of intrahepatic metastasis and portal vein thrombosis (p&amp;#60;0.05, R&amp;#61;0.998). Radiopaque material injected directly into 23 resected tumors entered only the portal vein in 17 tumors and into both the portal and hepatic veins in 6 tumors. In all 8 patients with unresectable lesions, radiopaque media injected percutaneously into tumor nodules flowed only into the portal vein. These findings suggest that intrahepatic invasion by HCC may occur through the portal vein as an efferent tumor vessel.</description><Author>Akihiro Toyosaka, Eizo Okamoto, Masao Mitsunobu, Takeshi Oriyama, Norio Nakao, and Koui Miura</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>A Different Method of Hepaticojejunostomy for Proximal Biliary Injuries</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/79783</link><description>The management of proximal biliary injuries presents a surgical challenge. Anastomoses can be difficult to perform and can have poor results. We describe a method of hepaticojejunostomy done from within the Roux-en-Y loop, which can be utilized in this situation.</description><Author>Diane M. Radford and Glennon Schaefer</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Obstructive Jaundice Associated with Polcystic Liver Disease</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/83547</link><description>A 65 year old patient with polycystic liver disease presented with obstructive jaundice thought to be a cholangiocarcinoma. Subsequent investigations demonstrated a large cyst compressing the confluence of the hepatic ducts. Percutaneous decompression of the biliary tree led to a complication necessitating surgery. Treatment options for symptomatic polycystic liver disease are reviewed.</description><Author>J. Dmitrewski, S. Olliff, and J. A. C. Buckels</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Isolated Resection of Segment I (Caudate Lobe): Is it Justified&amp;#63;</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/87129</link><description>Background: Isolated caudate lobectomy is a challenging surgical procedure for which safe and reliable techniques have yet to be developed.</description><Author>Leslie H. Blumgart</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>The Relationship between Portal Venous and Hepatic Arterial Blood Flow. I. Experimental Liver Transplantation</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/90536</link><description>The relationship between the changes in portal venous and hepatic arterial blood flows, in the liver is a much disputed question, it has tremendous significance in the practice of transplantation, and an explanation has been available since 1981, when Lautt published the so-caled &amp;#8220;adenosine washout theory&amp;#8221;. According to our earlier observations the decrease of portal pressure or flow consistently led to an increase in hepatic artery flow. At the same time changes in hepatic artery flow or pressure seemed to produce only inconsistent effects on the portal circulation. In the present experiments liver transplantation (OLTX) was carried out on mongrel dogs by Starzl&amp;#39;s method. Electromagnetic flow probes were placed on the hepatic artery and the portal vein before removal of recipient’s liver, and after completion of all vascular anastomoses to the newly inserted liver, during the recirculatory phase of OLTX. The flow probes were connected to a Hellige electromagnetic flowmeter, portal venous and systemic arterial pressures were also recorded.</description><Author>F. Jakab, I. Sug&amp;#225;r, Z. R&amp;#225;th, P. N&amp;#225;gy, and J. Faller</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Improved Results for Resection of Periampullary Adenocarcinoma</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/91791</link><description>Background: This study evaluates the indications for and effects of pancreaticoduodenectomy (102 patients) or total pancreatectomy (15 patients) with extensive lymph node dissection performed upon 117 patients for treatment of periampullary adenocarcinoma.</description><Author>H. Obertop and D. J. Gouma</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Development of Collaterals in Intermittent and Permanent Ischemia of the Liver</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1996/94108</link><description>The ischemia caused by hepatic dearterialization as therapy for hepatic malignancies is transient because of the rapid formation of collaterals. In order to prevent this transient repeated ischemia has been suggested.</description><Author>Engin Ok, Zeki Yilmaz, Erhan Akg&amp;#252;n, Erdo&amp;#287;an M. S&amp;#246;z&amp;#252;er, Ya&amp;#351;ar Ye&amp;#351;ilkaya, and Figen &amp;#214;zt&amp;#252;rk</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item><item><title>Treatment of a Giant Haemangioma of the Liver With Kasabach-Merritt Syndrome by Orthotopic Liver Transplant</title><link>http://www.hindawi.com/GetArticle.aspx?doi=10.1155/1997/10136</link><description>We describe a case of giant cavernous haemangioma of the liver with disseminated intravascular coagulopathy (Kasabach-Merritt syndrome) which was cured by orthotopic liver transplant.</description><Author>J-H. Longeville, P. De La M. Hall, P. Dolan, A. W. Holt, P. E. Lillie, J. A. R. Williams, and R. T. A. Padbury</Author><copyright>&amp;#169; 2008, Hindawi Publishing Corporation. All rights reserved.</copyright></item></channel></rss>